| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 09/03/2009 | WO2009061447A9 Treatment of premature birth complications |
| 09/03/2009 | WO2009055084A3 Vitamin c compositions |
| 09/03/2009 | WO2009055054A3 Antibody-mediated disruption of quorum sensing in bacteria |
| 09/03/2009 | WO2009053487A3 Proteins that stimulate the secretion of satiety hormones |
| 09/03/2009 | WO2009049742A3 Use of melanotrophin-potentiating factor as a therapeutic agent |
| 09/03/2009 | WO2009046829A3 Casoxin d as a therapeutic agent |
| 09/03/2009 | WO2009043480A3 Use of leptin (22-56 ) as a therapeutic agent |
| 09/03/2009 | WO2009043469A3 Use of pneumadin as a therapeutic agent |
| 09/03/2009 | WO2009043466A3 Therapeutic use of the peptide gluten exorphin a5 |
| 09/03/2009 | WO2009043455A3 Therapeutic uses of angiogenin 108-122 and gluten exorphin a5 |
| 09/03/2009 | WO2009042895A3 Reagents for inducing an immune response |
| 09/03/2009 | WO2009040018A3 Use of a peptide as a therapeutic agent |
| 09/03/2009 | WO2009040017A3 Use of a peptide as a therapeutic agent |
| 09/03/2009 | WO2009039993A3 Use of melanocyte-stimulating hormone release-inhibiting factor as a therapeutic agent in the treatment of pseudomonas aeruginosa infection |
| 09/03/2009 | WO2009039992A3 Use of band 3 protein (824-829) and/or melanocyte-stimulating hormone release-inhibiting factor as a therapeutic agent in the treatment of pseudomonas aeruginosa infection |
| 09/03/2009 | WO2009039988A3 Use of a fibrinogen receptor antagonist and/or follicular gonadotropin releasing peptide as a therapeutic agent in the treatment of streptococcus pneumonia infection |
| 09/03/2009 | WO2009033802A3 Antide as a therapeutic agent |
| 09/03/2009 | WO2009033801A3 Syndyphalin alone or in combination with antide as a therapeutic agent |
| 09/03/2009 | WO2009033755A3 Use of l-carnosine as a therapeutic agent |
| 09/03/2009 | WO2009033741A3 Use of lvv-hemorphin-6 and optionally af12198 as therapeutic agent(s) |
| 09/03/2009 | WO2009033737A3 Use of gluten exorphin c : as a therapeutic agent |
| 09/03/2009 | WO2009033731A3 Use of a laminin peptide as a therapeutic agent |
| 09/03/2009 | WO2009033723A3 Use of aip2 as a therapeutic agent |
| 09/03/2009 | WO2009033714A3 Use of a peptide as a therapeutic agent |
| 09/03/2009 | WO2009033692A3 Use of the peptides fibrinopeptide a and pyx-i as a therapeutic agents |
| 09/03/2009 | WO2009033665A3 Use of a rgd-peptide and/or parathyroid hormone (1-34 ) as anti-hiv agent |
| 09/03/2009 | WO2009033656A3 Use of follicular gonadotropin releasing peptide as a therapeutic agent in the treatment of streptococcus pneumoniae infection |
| 09/03/2009 | WO2009027823A9 Pharmaceutical composition for selective stimulation of wound healing processes, dermal-epidermal normal tissular trophism processes, its preparation and application. |
| 09/03/2009 | WO2009026282A3 Compositions for the treatment of stroke or cerebrovascular accidents with an endothelin b receptor agonist |
| 09/03/2009 | WO2009023777A3 Methods for treating immune thrombocytopenia |
| 09/03/2009 | WO2009021121A3 Identification and characterization of hcv replicon variants with reduced susceptibility to a combination of polymerase and protease inhibitors, and methods related thereto |
| 09/03/2009 | WO2009004057A3 Mutated dimeric prolactin receptor ligands |
| 09/03/2009 | WO2008143884A3 Media and devices for cold storage of therapeutic cells |
| 09/03/2009 | WO2008103690A3 Prevention and treatment for osteonecrosis and osteoradionecrosis of the jaw using pdgf and a bone matrix |
| 09/03/2009 | WO2008092281A8 Template-fixed peptidomimetics |
| 09/03/2009 | WO2008084072A3 Protective proteins of s. agalactiae, combinations thereof and methods of using the same |
| 09/03/2009 | WO2007075906A3 Improved thyroid-stimulating hormone receptor polypeptide agonist glycoforms to treat metabolic syndrome |
| 09/03/2009 | US20090221985 System for iontophoretic transdermal delivery of polymeric agents and methods of use thereof |
| 09/03/2009 | US20090221807 2' Deoxy-2'-Alkylnucleotide Containing Nucleic Acid |
| 09/03/2009 | US20090221805 Complex polymere amphiphile-PDGF |
| 09/03/2009 | US20090221802 heterodimeric receptor complex comprising a receptor polypeptide and a interleukin-2 gamma receptor polypeptide, used for detecting ligands that stimulate the proliferation and/or development of hematopoietic, lymphoid and myeloid cells in vitro and in vivo; antibodies; immunology |
| 09/03/2009 | US20090221713 Apoe mimetic agents |
| 09/03/2009 | US20090221706 Methods of treating cognitive dysfunction by modulating brain energy metabolism |
| 09/03/2009 | US20090221686 Modulation of the Transcription of Pro-Inflammatory Gene Products |
| 09/03/2009 | US20090221676 Glucose-transport related genes, polypeptides, and methods of use thereof |
| 09/03/2009 | US20090221514 Methods for prevention and treatment of acute renal injury |
| 09/03/2009 | US20090221513 Treatment of Neurodegenerative Disorders |
| 09/03/2009 | US20090221512 Pharmaceutical composition containing ghrp-6 to prevent and eliminate fibrosis and other pathological deposits in tissues |
| 09/03/2009 | US20090221511 Trpv1 + sensory neurons control of beta-cell stress and islet inflammation in diabetes |
| 09/03/2009 | US20090221510 Erythropoietin receptor peptide formulations and uses |
| 09/03/2009 | US20090221509 Tumour-associated peptides binding to MHC-molecules |
| 09/03/2009 | US20090221508 Immunomodulatory and anti-tumour peptides |
| 09/03/2009 | US20090221507 administering peptide sequence tyr-ser-met-lys-lys-thr-thr-met-lys-ile-ile-pro-phe-asn-arg-leu-thr-ile-gly to a mammal to treat degenerative disorder of the nervous system involves leakage of fibrinogen perivascularly in the brain; multiple sclerosis, spinal cord injury, stroke and Alzheimer's Disease |
| 09/03/2009 | US20090221506 Gdnf derived peptides |
| 09/03/2009 | US20090221505 Compositions and methods related to synchronous selection of homing peptides for multiple tissues by in vivo phage display |
| 09/03/2009 | US20090221504 Dose of an angiogenic factor and method of administering to improve myocardial blood flow |
| 09/03/2009 | US20090221503 Use of rapamycin and rapamycin derivatives for the treatment of bone loss |
| 09/03/2009 | US20090221502 Vegetarian anabolic protein composition |
| 09/03/2009 | US20090221501 toxin complex (TC) proteins, obtained from Xenorhabdus, Photorhabdus, and Paenibacillus; toxicity of an insectidal protein is enhanced by a potentiator protein of a different organism; reduces the number of genes (and transformation events) needed to be coexpressed by transgenic plants for insect control |
| 09/03/2009 | US20090221500 Modified toxins |
| 09/03/2009 | US20090221499 Production in E. coli of a lipidated fusion protein containing a lipidating sequence derived from Ag473 and a target polypeptide; for use in induction of immune responses |
| 09/03/2009 | US20090221498 Use of Mas-G-Protein-Coupled Receptor Agonists in the Treatment of the Metabolic Syndrome, Its Components and its Complications |
| 09/03/2009 | US20090221497 Immunodynamic complexes and methods for using and preparing such complexes |
| 09/03/2009 | US20090221496 novel antithrombotic agent |
| 09/03/2009 | US20090221495 Treatments for neurological disorders |
| 09/03/2009 | US20090221494 Method of modulating cellular activity and agents for use therein |
| 09/03/2009 | US20090221493 Ocl-2a3 compositions and uses thereof |
| 09/03/2009 | US20090221492 Expression of active human factor ix in mammary tissue of transgenic animals |
| 09/03/2009 | US20090221491 Purification and Use of a Factor for Supporting Wound Healing |
| 09/03/2009 | US20090221490 Endothelin Receptors In Morphine Withdrawal |
| 09/03/2009 | US20090221489 Water-Soluable Films Comprising Low-Viscosity Alginates |
| 09/03/2009 | US20090221488 Certain Compositions and Methods of Treatment |
| 09/03/2009 | US20090221487 Polyethlene glycol modifications of thymosin alpha-1 |
| 09/03/2009 | US20090221486 Method for treating and/or preventing infections in infants delivered via caesarean section |
| 09/03/2009 | US20090221485 Oral peptides conjugates for metabolic diseases |
| 09/03/2009 | US20090221484 Use of Factor VII Polypeptides for Neuroprotection |
| 09/03/2009 | US20090221483 Antimicrobial Cathelicidin Peptides |
| 09/03/2009 | US20090221482 Tissue protective peptides and uses thereof |
| 09/03/2009 | US20090221481 Stimulatory auto-antibodies to the pdgf receptors as pathology marker and therapeutic target |
| 09/03/2009 | US20090221480 Kallikrein Inhibitors and Anti-Thrombolytic Agents and Uses Thereof |
| 09/03/2009 | US20090221479 Lgi, lingo and p75ntr family members: novel modulators of neuronal growth |
| 09/03/2009 | US20090221478 Novel galectin sequences and compositions and methods utilizing same for treating or diagnosing arthritis and other chronic inflammatory diseases |
| 09/03/2009 | US20090221477 Linkers |
| 09/03/2009 | US20090221476 Peptide Capable of Altering Tubulin Polymerization and use Thereof for Inhibiting Cell Proliferation |
| 09/03/2009 | US20090221475 Treatment of lung disorders |
| 09/03/2009 | US20090221474 Histone deacetylases, and uses related thereto |
| 09/03/2009 | US20090221473 Antitumor agents |
| 09/03/2009 | US20090221472 Method for treating transplant rejection |
| 09/03/2009 | US20090221471 Prodrugs of vancomycin with hydrolysis resistant polymer linkages |
| 09/03/2009 | US20090221470 Use of an echinocandin antifungal agent in combination with a glycopeptide antibacterial agent |
| 09/03/2009 | US20090221469 Use of soy kefir powder for reducing pain, blood pressure and inflammation |
| 09/03/2009 | US20090221468 Autonomously Replicating KSHV CIS-Acting Elements |
| 09/03/2009 | US20090221036 Recombinant anti-cd4 antibodies for human therapy |
| 09/03/2009 | US20090220967 Systemic Carnitine Deficiency Gene and Uses Thereof |
| 09/03/2009 | US20090220608 Pharmaceutical composition of microspheres for preventing diabetic foot amputation |
| 09/03/2009 | US20090220607 Polymeric compositions and methods of making and using thereof |
| 09/03/2009 | US20090220595 Combination of erythropoietin glycoisoforms |
| 09/03/2009 | US20090220588 Simultaneous Delivery of Receptors and/or Co-Receptors for Growth Factor Stability and Activity |
| 09/03/2009 | US20090220586 Proteomimetic compounds as inhibitors of the interaction of nuclear receptor with coactivator peptides |
| 09/03/2009 | US20090220581 Methods of reducing inflammation and mucus hypersecretion |